共 50 条
- [1] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey [J]. Allergy, Asthma & Clinical Immunology, 13
- [2] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
- [10] The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (09): : 1048 - 1058